ADC Education & Practice

Beyond the Milestones: An unusual case of Developmental Delay

A 9-month-old male was referred due to developmental concerns, including being unable to sit unsupported and persistent head ...
manilatimes

Novo’s Wegovy® (semaglutide) reduced liver fat to normal levels in 9 out of 10 adults with obesity and excess liver fat - EASD2026

Novo reports analysis from STEP UP trial sub-population in which most participants with elevated liver fat achieved improved liver health after 72 weeks of Wegovy®(injectable semaglutide 7.2 and 2.4 ...
BMJ Case Reports

Rotavirus-associated mild encephalitis with a reversible splenial lesion of the corpus callosum

We report a case of mild encephalitis/encephalopathy with a reversible splenial lesion (MERS) of the corpus callosum ...

Johnson & Johnson announces TREMFYA® (guselkumab) is the first and only IL-23 inhibitor to show significant improvement in spinal pain and stiffness in landmark axial ...

Johnson & Johnson (NYSE: JNJ) today announced that TREMFYA® (guselkumab) met the primary and major secondary endpoints demonstrating both improvement in axial symptoms and reduction in inflammation by ...
bjo.bmj

OCT-based myopic index: a biological predictor for the progression of high myopia

Background The growth of axial length (AL) can lead to high myopia and ocular deformation, especially causing microstructural changes in the fundus, which cannot be fully quantified by AL alone. We ...